The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Recombinant human activated protein C reduces human endotoxin-induced pulmonary inflammation via inhibition of neutrophil chemotaxis
Open accessAbstract
Recombinant human activated protein C (rhAPC) is a natural anticoagulant with potentially important anti-inflammatory properties. In humans with severe sepsis, rhAPC treatment reduces mortality, but mechanisms responsible have not been well characterized. Accumulation of activated neutrophils in the lungs and other organs during severe infection contributes to sepsis-induced organ dysfunction, including acute inflammatory lung injury. Because neutrophils express an APC receptor, we hypothesized that immunomodulatory effects of rhAPC occur, in part, via modulation of neutrophil responses. To examine this issue, we performed a double-blinded, placebo-controlled study of rhAPC in a human model of endotoxin-induced pulmonary inflammation. Administration of rhAPC significantly reduced leukocyte accumulation to the airspaces, independent of pulmonary cytokine or chemokine release. Neutrophils recovered from bronchoalveolar lavage fluid of volunteers receiving rhAPC demonstrated decreased chemotaxis ex vivo. Decreased neutrophil chemotaxis following exposure to rhAPC was confirmed in vitro. No differences were detected in gene expression, kinase activation, cytokine release, cell survival, or apoptosis of neutrophils recovered in the presence or absence of rhAPC. These studies demonstrate that rhAPC reduces both endotoxin-induced accumulation of leukocytes in the airspaces and neutrophil chemotaxis. These rhAPC-induced effects on neutrophil function may represent a mechanism by which rhAPC improves survival in patients with sepsis. (Blood. 2004;104:3878-3885)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Savill, J. S., Wyllie, A. H., Henson, J. E., Walport, M. J., Henson, P. M., & Haslett, C. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113970 · Cited by 1,536
Cited by
WHO-EORTC classification for cutaneous lymphomas
Willemze, R. (2005) · Blood · doi:10.1182/blood-2004-09-3502 · Cited by 3,803
Levi, M., & van der Poll, T. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181c98d21 · Cited by 984
The cytoprotective protein C pathway
Mosnier, L. O., Zlokovic, B. V., & Griffin, J. H. (2007) · Blood · doi:10.1182/blood-2006-09-003004 · Cited by 754
Neutrophils in development of multiple organ failure in sepsis
Brown, K., Brain, S., Pearson, J., Edgeworth, J., Lewis, S., & Treacher, D. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69005-3 · Cited by 660
Matthay, M. A., & Zimmerman, G. A. (2005) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.f305 · Cited by 642
Metadata
- Authors
- Nick, J. A., Coldren, C. D., Geraci, M. W., Poch, K. R., Fouty, B. W., O'Brien, J., Gruber, M., Zarini, S., Murphy, R. C., Kuhn, K., Richter, D., Kast, K. R., & Abraham, E.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2004-12-15
- Volume
- 104
- Issue
- 13
- Pages
- 3878-3885
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2146884753
- Cited by
- 221
- References
- 1
- FWCI
- 16.88
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Recombinant human activated protein C reduces human endotoxin-induced pulmonary inflammation via inhibition of neutrophil chemotaxis. https://app.cochat.ai/papers/10.1182/blood-2004-06-2140
- The paper
- Nick, J. A., Coldren, C. D., Geraci, M. W., Poch, K. R., Fouty, B. W., O'Brien, J., Gruber, M., Zarini, S., Murphy, R. C., Kuhn, K., Richter, D., Kast, K. R., & Abraham, E. (2004). Recombinant human activated protein C reduces human endotoxin-induced pulmonary inflammation via inhibition of neutrophil chemotaxis. Blood. https://doi.org/10.1182/blood-2004-06-2140
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.